Arkolith/Insider Trading/IBO/Form 4

Heuszel Frank D

Chief Executive Officer, DirectorIMPACT BIOMEDICAL INC. (IBO) · full profile →Form 4 · filed Dec 3, 2024
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2024Buy(P)500$2.59$1K96K
Nov 26, 2024Buy(P)550$2.63$1K96K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-048576) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML